Caina Technology Co., Ltd.

Shenzhen Stock Exchange 301122.SZ

Caina Technology Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 254.46 M

Caina Technology Co., Ltd. Shareholders' Equity is USD 254.46 M for the year ending December 31, 2023, a 1.13% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Caina Technology Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 251.61 M, a 213.41% change year over year.
  • Caina Technology Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 80.28 M, a 38.11% change year over year.
  • Caina Technology Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 58.13 M, a 133.30% change year over year.
  • Caina Technology Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 24.92 M, a 54.13% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Shenzhen Stock Exchange: 301122.SZ

Caina Technology Co., Ltd.

CEO Mr. Jun Lu
IPO Date Jan. 26, 2022
Location China
Headquarters No. 23, Huaxi Road
Employees 689
Sector Health Care
Industries
Pharmaceuticals Biotechnology Medical Instruments
Description

Caina Technology Co., Ltd. engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. The company was founded in 2004 and is based in Jiangyin, China.

StockViz Staff

January 16, 2025

Any question? Send us an email